Swine Flu Vaccine Productions

Posted by admin | Posted in preparation | Posted on 06-07-2009

To discuss and make strong decisions to fight the widespread Swine Flu, the

World Health Organization set a meeting with the vaccine manufacturers

together with other health experts to stop the Swine Flu Outbreak. 

Different Pharmaceutical companies are ready to begin making a Swine Flu

vaccine — but as the virus may alter, there are questions formed:

How much should they have to produce? How will the government distribute

the vaccines to the infected areas? Who should get it, babies, youngsters,

adults, men, women, pregnant?

Most flu vaccine companies mentioned that they can only make one vaccine at

a time: either seasonal flu vaccine or pandemic vaccine.  Production takes

months and it is impossible to switch halfway through if health officials

make a mistake.  Vaccine makers can make limited amounts of both seasonal

flu vaccine and pandemic vaccine — though not at the same time — but they

cannot make massive quantities of both because that exceeds manufacturing

capacity.

Even if we are in the modern era, still the health officials have a big

problem to solve the spreading of deadly swine flu is, and whether they

will need more seasonal flu vaccine or swine flu vaccine.  Scientists are

not sure the effectiveness of a vaccine, if the swine flu will transmute. 

Only two billion doses of swine flu vaccine could be produced annually

based on the estimation of World Health Organization officials, though the

first batches wouldn’t be available for four to six months.

A “seed stock” to make the vaccine, which should be ready and it will be

distributed to manufacturers worldwide so they can start producing the

vaccine is now on the go as the U.S. Centers for Disease Control and

Prevention works on.  After the vaccine manufacturers get the seed stock,

they won’t know how many doses of vaccine they can make or how long that

would take.

Including vaccine producer, GlaxoSmithKline PLC, the World Health

Organization is under negotiation process to save some of their swine flu

vaccine for poorer nations.  A couple of years ago members of the rich

nations like United States, Switzerland, France, Denmark, Canada and

Britain signed deals with the vaccine makers to guarantee them pandemic

vaccines as soon as they’re available.

Cipla (The pharmaceuticals giant in India) instructed by the World Health

Organization to make a generic version of Tamiflu antiviral drug.  Tamiflu

also known as oseltamivir, one of the two antiviral drugs to treat the

Swine Flu.  Then WHO said Cipla’s generic version was more effective than

the original made by Swiss firm Roche Holding AG and would hopefully make

the drug more accessible to the third world countries.  As we all know that

Indian pharmaceuticals produce drugs in very affordable prices.

North America has been the hardest-hit continent for the Swine Flu virus

that kills two Americans from Texas (including a pregnant woman) and one in

Washington.  If the vaccine productions are enough to all suspected Swine

Flu carrier, it won’t happen again that a simple pregnant woman died

fighting the virus. 

Through this article, we will inform the public of an early planning and

prevention against Swine Flu for their safety.  Consult to the Health

Officers about planning and prevention against the virus.  According to an

unidentified source that one out of three Americans can only take the

Tamiflu.

Post your comment

Spam Protection by WP-SpamFree